Equities

Kainos Laboratories Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
4556:TYO

Kainos Laboratories Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)2,277.00
  • Today's Change0.00 / 0.00%
  • Shares traded42.80k
  • 1 Year change+88.34%
  • Beta1.2422
Data delayed at least 15 minutes, as of Feb 13 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

KAINOS Laboratories, Inc. is pricipally engaged in researching, developing, manufacturing and selling clinical diagnostic reagents, including biochemical diagnostic reagents such as renal function related reagents and automatic biochemical analytical reagents, immune serological test reagents such as transfusion-related reagents, allergy-related reagents, cancer marker related reagents, and other reagents.

  • Revenue in JPY (TTM)5.46bn
  • Net income in JPY597.66m
  • Incorporated1975
  • Employees157.00
  • Location
    Kainos Laboratories Inc2-38-18, HongoBUNKYO-KU 113-0033JapanJPN
  • Phone+81 338164123
  • Fax+81 338166550
  • Websitehttps://www.kainos.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Leoclan Co Ltd21.49bn152.78m5.80bn155.0038.811.0322.200.270125.2525.253,629.27951.552.00397.095.36138,642,100.001.602.342.634.7812.7611.260.7991.202.23--0.001234.118.51-0.465612.294.8012.954.98
Data Horizon Co Ltd5.18bn-2.30bn6.14bn367.00--20.34--1.19-181.31-181.31407.7923.740.746621.802.4414,102,500.00-33.20---54.27--36.77---44.47--1.29-3.050.9424--------------
Precision System Science Co Ltd4.93bn-119.23m6.61bn151.00--1.7157.901.34-4.33-4.33180.08140.170.88232.206.4532,653,930.00-2.13-4.14-2.94-5.5529.1430.20-2.42-6.051.50-1.020.1602--17.91-1.5277.43---25.44--
Aso International Inc3.88bn470.10m7.25bn310.0015.692.4714.131.8747.1647.16389.31299.861.2416.267.6612,519,540.0014.96--16.69--45.12--12.11--7.0149.710.00--7.10--13.50------
Yamashita Health Care Holdings Inc63.77bn412.00m9.11bn613.0021.530.998314.240.1429165.78165.7825,574.613,576.032.4314.255.39104,027,700.001.562.244.396.5313.5013.100.6430.89750.945--0.0032.954.76-0.05346.216.0343.356.79
Koken Ltd11.86bn885.29m9.68bn321.0010.550.67577.430.8162179.77179.772,408.462,805.840.54762.482.30--4.093.905.214.9545.4045.897.477.411.6823.740.295719.1510.173.1522.611.11-11.116.96
JTEC Corp1.93bn45.31m10.34bn76.00227.783.8850.245.377.697.69326.97450.770.56051.7126.4925,335,010.001.321.761.491.9961.0259.572.353.782.5519.790.15410.00-4.2213.39-69.7629.84-17.34--
Kainos Laboratories Inc5.46bn597.66m10.38bn157.0016.061.3514.861.90141.77141.771,294.101,688.390.61923.033.0734,748,430.006.787.128.129.3248.0951.5710.9611.493.45--0.071721.114.932.850.47879.976.9016.36
JMS Co Ltd66.09bn-224.00m11.06bn5.47k--0.26254.610.1673-9.15-9.152,695.911,703.210.76512.443.5412,084,290.00-0.36580.7427-0.53821.1022.7723.52-0.47810.88361.076.050.393671.626.833.56347.22-46.21-1.640.00
Create Medic Co Ltd13.57bn762.91m11.16bn1.00k13.190.61998.350.822487.6087.601,563.181,863.230.71481.824.9413,545,480.004.023.044.543.5844.6244.515.624.635.1741.710.045860.323.533.74445.963.0114.010.00
Japan Medical Dynamic Marketing Inc24.58bn-1.05bn13.18bn538.00--0.522424.420.5363-40.02-40.02933.26953.320.72020.63684.3445,695,190.00-3.134.27-3.804.9459.9365.20-4.355.781.2812.480.180228.508.356.79-136.31---1.378.45
OLBA Healthcare Holdings Inc124.48bn1.43bn13.22bn1.39k8.771.056.330.1062241.07241.0721,003.792,008.322.7716.234.8089,362,800.003.173.439.9111.3911.2611.491.151.220.958266.630.225530.513.492.61-4.6834.3828.7114.87
DVx Inc55.33bn308.75m13.28bn334.0041.821.4812.290.2429.4629.465,278.63831.732.2417.684.12165,663,400.001.252.643.286.459.6011.080.5581.281.23--0.002563.099.752.42137.18-12.33-2.4315.81
Daiken Medical Co Ltd10.17bn981.12m15.28bn180.0014.051.7912.441.5034.1534.15353.89267.890.90354.563.6456,482,360.008.727.8611.8311.2538.7941.239.659.511.89183.100.193969.412.073.1511.035.01-0.18892.83
Data as of Feb 13 2026. Currency figures normalised to Kainos Laboratories Inc's reporting currency: Japanese Yen JPY
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.